Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Inflammation risk before cardiac surgery and the treatment effect of intraoperative dexamethasone

Patients who exhibit high systemic inflammation after cardiac surgery may benefit most from pre-emptive anti-inflammatory treatments. In this secondary analysis of the randomised, double-blind Intraoperative High-Dose Dexamethasone for Cardiac Surgery trial, we set out to develop an inflammation risk prediction model and assess whether patients at higher risk benefit from a single intraoperative dose of dexamethasone.

Citation:
Toner AJ, Corcoran TB, Vlaskovsky PS, Nierich AP, et al. Inflammation risk before cardiac surgery and the treatment effect of intraoperative dexamethasone. Anaesth Intensive Care. 2023   

Keywords:
Inflammation risk; dexamethasone; surgery

Abstract:
Patients who exhibit high systemic inflammation after cardiac surgery may benefit most from pre-emptive anti-inflammatory treatments. In this secondary analysis of the randomised, double-blind Intraoperative High-Dose Dexamethasone for Cardiac Surgery trial, we set out to develop an inflammation risk prediction model and assess whether patients at higher risk benefit from a single intraoperative dose of dexamethasone.